1 – 19 of 19
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Identification of a serum biomarker signature associated with metastatic prostate cancer
(
- Contribution to journal › Article
-
Mark
Placebo comparator group selection and use in surgical trials : The aspire project including expert workshop
(
- Contribution to journal › Article
- 2020
-
Mark
Considerations and methods for placebo controls in surgical trials (ASPIRE guidelines)
(
- Contribution to journal › Scientific review
- 2019
-
Mark
Increased EZH2 expression in prostate cancer is associated with metastatic recurrence following external beam radiotherapy
(
- Contribution to journal › Article
- 2018
-
Mark
Value of Intact Prostate Specific Antigen and Human Kallikrein 2 in the 4 Kallikrein Predictive Model : An Individual Patient Data Meta-Analysis
(
- Contribution to journal › Article
- 2017
-
Mark
Properties of the 4-Kallikrein Panel Outside the Diagnostic Gray Zone : Meta-Analysis of Patients with Positive Digital Rectal Examination or Prostate Specific Antigen 10 ng/ml and Above
(
- Contribution to journal › Article
- 2016
-
Mark
The profile feasibility study : Targeted screening of men with a family history of prostate cancer
(
- Contribution to journal › Article
- 2015
-
Mark
Predicting High-Grade Cancer at Ten-Core Prostate Biopsy Using Four Kallikrein Markers Measured in Blood in the ProtecT Study.
(
- Contribution to journal › Article
-
Mark
Altered expression of epithelial-to-mesenchymal transition proteins in extraprostatic prostate cancer.
2015) In Oncotarget(
- Contribution to journal › Article
-
Mark
Achievements and Perspectives in Prostate Cancer Phase 3 Trials from Genitourinary Research Groups in Europe: Introducing the Prostate Cancer Consortium in Europe.
(
- Contribution to journal › Scientific review
- 2014
-
Mark
Evaluating the Prostate Cancer Prevention Trial High Grade prostate cancer risk calculator in 10 international biopsy cohorts : Results from the prostate biopsy collaborative group
(
- Contribution to journal › Article
-
Mark
Prevention and early detection of prostate cancer.
(
- Contribution to journal › Scientific review
-
Mark
Targeted Prostate Cancer Screening in BRCA1 and BRCA2 Mutation Carriers: Results from the Initial Screening Round of the IMPACT Study.
2014) In European Urology(
- Contribution to journal › Article
- 2013
-
Mark
Prospective randomized evaluation of risk-adapted prostate-specific antigen screening in young men : The PROBASE trial
(
- Contribution to journal › Article
- 2012
-
Mark
Current Vaccination Strategies for Prostate Cancer
(
- Contribution to journal › Scientific review
-
Mark
Importance of prostate volume in the European Randomised Study of Screening for Prostate Cancer (ERSPC) risk calculators : Results from the prostate biopsy collaborative group
(
- Contribution to journal › Article
-
Mark
Evaluating the PCPT risk calculator in ten international biopsy cohorts : Results from the Prostate Biopsy Collaborative Group
(
- Contribution to journal › Article
- 2011
-
Mark
MicroRNA in Prostate, Bladder, and Kidney Cancer: A Systematic Review
(
- Contribution to journal › Scientific review
- 2010
-
Mark
The relationship between prostate-specific antigen and prostate cancer risk : The prostate biopsy collaborative group
(
- Contribution to journal › Article